In line with its US pursuit, medical equipment manufacturer Optiscan Imaging (ASX: OIL) has signed a know-how agreement with the US-based academic medical centre Mayo Clinic to develop a new endomicroscopic imaging system. The companies will work together to co-develop technology for use in robotic surgery. The global market size for medical robots is set
Read More
Over 20,000 Aussies are diagnosed with breast cancer every year and is the most commonly diagnosed cancer among women in the country. Therefore, early detection is crucial, and medical imaging is a large part of it. Given that, medical imaging tech provider Optiscan Imaging (ASX: OIL) is conducting a Breast Cancer Intraoperative Assessment study. The
Read More
Would you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah, heck yes. Endomicroscopic imaging tech company Optiscan Imaging (ASX: OIL) has entered into a binding Terms Sheet with Managing Director, Prof Camile Farah, to acquire intellectual property in the form of clinical and histopathological datasets.
Read More
With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in vivo microscopic imaging camera which can be thread through the human body for use in cancer detection and surgery. The increased exposure will come through a freshly inked distribution partnership with biotech company Sinsi Technology
Read More